e-learning
resources
Munich 2006
Monday 04.09.2006
Established and experimental therapies for allergic asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
E. M. Ditiatkovskaya, I. A. Rodkina, V. E. Makarenko, J. V. Bendetskaya, V. A. Ditiatkovsky (Dnipropetrovsk, Ukraine)
Source:
Annual Congress 2006 - Established and experimental therapies for allergic asthma
Session:
Established and experimental therapies for allergic asthma
Session type:
Thematic Poster Session
Number:
2556
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. M. Ditiatkovskaya, I. A. Rodkina, V. E. Makarenko, J. V. Bendetskaya, V. A. Ditiatkovsky (Dnipropetrovsk, Ukraine). Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis. Eur Respir J 2006; 28: Suppl. 50, 2556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002
House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020
Impact of asthma-associated genetic polymorphisms on the efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021
Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006
Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006
Circulating platelets activity in patients sensitised to house dust mite suffering from persistent allergic rhinitis with or without asthma symptoms
Source: Eur Respir J 2005; 26: Suppl. 49, 590s
Year: 2005
Efficacy of specific allergy vaccination in house dust mite asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 465s
Year: 2005
Adherence to sublingual immunotherapy in patients allergic to mites
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
OPURIT:
O
malizumab-
p
rotected
u
ltra
r
ush
s
pecific
i
mmunotherapy in severe asthmatic patients with house dust mite allergy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Allergen exposure in nondog and nonhouse dust mite sensitized atopic asthmatic subjects; effect on bronchial reactivity
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001
Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM)
Source: Eur Respir J 2002; 20: Suppl. 38, 172s
Year: 2002
Phospho-STAT-6 levels in nasal scrapings of asthmatic patients increases following nasal challenge with grass but not house dust mite allergen
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Late-breaking abstract: Bronchial allergen challenge with
D. Pteronyssinus
inhibit blood neutrophil apoptosis in patients with allergic asthma and rhinitis
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011
High-altitude treatment in atopic and nonatopic patients with severe asthma
Source: Eur Respir J 2012; 40: 1374-1380
Year: 2012
Calcaratarin D attenuates house dust mite-induced allergic asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept